MedTech Dive December 8, 2023
Edwards is the latest healthcare firm to spin off a business to focus on specific markets, following larger companies like Johnson & Johnson and GE.
- Edwards Lifesciences plans to spin out its critical care unit as an independent company at the end of next year, continuing the trend of medtechs using spinoffs as a strategy to focus on specific businesses and markets.
- CEO Bernard Zovighian said during a Thursday investor day event that the spinoff will allow Edwards to focus on its cardiac businesses, such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral and tricuspid therapies (TMTT), and allow critical care to be more focused and flexible.
- Edwards also announced its 2024 financial forecast ahead of...